Challenges in Manufacturing of Advanced Therapies and Immunotherapeutics

Alan Moore, Vice President and Commercial Chief for Biologics and Advanced Therapies, WuXi App Tec

Video Overview

WuXi App Tec is a rapidly-growing global enterprise providing an integrated service for manufacturing, characterising and dispatching next-generation regenerative medical therapeutics at a commercial scale. Vice President Alan Moore provided the conference with a detailed overview of WuXi’s current capabilities and the complex workflow management involved in meeting stringent regulatory requirements within a very limited time, particularly in the case of autologous cell therapies.